REAL-WORLD DATA IN INFLAMMATORY BOWEL DISEASES ON VEDOLIZUMAB THERAPY: INTERIM ANALYSIS OF THE NON-INTERVENTIONAL LISTEN II STUDY
Hermann Schulze 1
Niels Teich 2
Andreas Stallmach 3
Taner Cavlar 4
Jana Knop
Sonja Henneberger 5
1 Agaplesion Markus-Hospital, Frankfurt am Main, Germany
2 Group Practice in Internal Medicine for Digestive and Metabolic Diseases, Leipzig, Germany
3 University Hospital Jena, Jena, Germany
4 Takeda Pharma Vertrieb GmbH & Co. KG, Berlin, Germany
5 Institut Dr. Schauerte GmbH, Munich, Germany
Topic
IBD
Session
PP 05 IBD (Posters)
Conference
UEG Week 2023
Citation
United European Gastroenterology Journal 2023; 11 (Supplement 8)
Login to access library content
Do you need help setting up your myUEG account?
Contact us at [email protected]